EdgarLookup

ABVC BIOPHARMA, INC. — All Filings

778 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-KT 10-Q 10-Q/A 10KSB 10KSB/A 10QSB 3 3/A 4 4/A 424B1 424B2 424B3 424B4 424B5 5 8-A12B 8-K 8-K/A AW CERT CORRESP D DEF 14A DEFA14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PREM14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-4 S-4/A S-8 S-8 POS SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-24-033598 Apr 17, 2024
424B4 PROSPECTUS 0001213900-24-030778 Apr 5, 2024
EFFECT 9999999995-24-000813 Apr 1, 2024
CORRESP 0001213900-24-027835 Mar 29, 2024
8-K CURRENT REPORT 0001213900-24-025793 Mar 26, 2024
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-24-025561 Mar 25, 2024
S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-24-025197 Mar 22, 2024
10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-24-022721 Mar 15, 2024 Dec 31, 2023
8-K FORM 8-K 0001213900-24-022451 Mar 14, 2024
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-24-022472 Mar 14, 2024
8-K CURRENT REPORT 0001213900-24-022396 Mar 14, 2024
10-K ANNUAL REPORT 0001213900-24-022235 Mar 13, 2024 Dec 31, 2023
8-K/A AMENDMENT NO.1 TO FORM 8K 0001213900-24-018526 Feb 29, 2024 Jan 16, 2024
8-K/A CURRENT REPORT 0001213900-24-018524 Feb 29, 2024 Nov 20, 2023
CORRESP 0001213900-24-014944 Feb 16, 2024
S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-24-014947 Feb 16, 2024
UPLOAD 0000000000-24-001731 Feb 13, 2024
SC 13G/A 0000929638-24-000554 Feb 13, 2024
S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-24-012141 Feb 9, 2024
CORRESP 0001213900-24-012140 Feb 9, 2024
8-K CURRENT REPORT 0001213900-24-011360 Feb 8, 2024
8-K/A AMENDMENT NO. 1 TO FORM 8-K 0001213900-24-006637 Jan 26, 2024 Nov 16, 2023
UPLOAD 0000000000-24-000807 Jan 22, 2024
8-K CURRENT REPORT 0001213900-24-004172 Jan 17, 2024
8-K CURRENT REPORT 0001213900-24-004194 Jan 17, 2024 Jan 16, 2024
8-K/A AMENDMENT NO. 1 TO FORM 8-K 0001213900-24-004199 Jan 17, 2024 Nov 20, 2023
S-1 REGISTRATION STATEMENT 0001213900-24-003415 Jan 12, 2024
DEF 14A PROXY STATEMENT 0001213900-23-100009 Dec 29, 2023 Jan 16, 2024
PRE 14A PROXY STATEMENT 0001213900-23-096178 Dec 15, 2023
8-K CURRENT REPORT 0001213900-23-088524 Nov 20, 2023
424B4 PROSPECTUS SUPPLEMENT 0001213900-23-088374 Nov 17, 2023
424B4 PROSPECTUS SUPPLEMENT 0001213900-23-088373 Nov 17, 2023
424B3 PROSPECTUS SUPPLEMENT 0001213900-23-088372 Nov 17, 2023
8-K CURRENT REPORT 0001213900-23-087740 Nov 16, 2023
8-K CURRENT REPORT 0001213900-23-087289 Nov 15, 2023
10-Q QUARTERLY REPORT 0001213900-23-087270 Nov 15, 2023 Sep 30, 2023
NT 10-Q NOTIFICATION OF LATE FILING 0001213900-23-087124 Nov 14, 2023 Sep 30, 2023
8-K CURRENT REPORT 0001213900-23-076241 Sep 13, 2023
8-K/A AMENDMENT NO. 1 TO FORM 8-K 0001213900-23-074145 Sep 6, 2023 Aug 17, 2023
8-K CURRENT REPORT 0001213900-23-072608 Aug 31, 2023
424B4 PROSPECTUS SUPPLEMENT NO. 2 DATED AUGUST 16, 2023. 0001213900-23-068605 Aug 17, 2023
424B4 PROSPECTUS SUPPLEMENT NO. 1 DATED AUGUST 16, 2023. 0001213900-23-068606 Aug 17, 2023
8-K CURRENT REPORT 0001213900-23-068359 Aug 17, 2023 Aug 14, 2023
424B3 PROSPECTUS SUPPLEMENT NO. 2 DATED AUGUST 16, 2023. 0001213900-23-068604 Aug 17, 2023
10-Q QUARTERLY REPORT 0001213900-23-067113 Aug 14, 2023 Jun 30, 2023
8-K/A AMENDMENT NO. 1 TO FORM 8-K 0001213900-23-065088 Aug 9, 2023 Aug 22, 2022
8-K CURRENT REPORT 0001213900-23-063832 Aug 7, 2023
SC 13G 0000929638-23-002183 Aug 7, 2023
8-K CURRENT REPORT 0001213900-23-062628 Aug 2, 2023
8-K CURRENT REPORT 0001213900-23-061038 Jul 31, 2023